Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
825 6 |
Ultima descărcare din IBN: 2023-02-20 13:49 |
SM ISO690:2012 CIOBANU, Liliana. Markerii cardiovasculari: valori predictive şi semnificaţii fiziopatologice. In: Curierul Medical, 2012, nr. 6(330), pp. 47-53. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | ||||||
Numărul 6(330) / 2012 / ISSN 1875-0666 | ||||||
|
||||||
Pag. 47-53 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The diagnostics arsenal of cardiovascular diseases is updated by the use of specific markers which are approved by European Society of Cardiology, American Heart Association and American College of Cardiology. In this article an actual glance of opportune markers applied in myocardial necrosis, myocardial remodeling and endothelium dysfunction estimation is emphasized. The role of CK-MB, myoglobin and troponins (I and T) is underlined in the necrotic myocardial lesions diagnosis. For myocardium remodeling is basically important estimation of the circulating levels of galectin-3, BNP, connective tissue growth factor and matrix metalloproteinases. Endothelial dysfunction of systemic and coronary arteries is linked to soluble selectines, inflammatory cytokines, lipoprotein-associated phospholipase A2, nitric oxide and asymmetric dimethylarginine assessment. |
||||||
Cuvinte-cheie biomarker, myocardium remodeling, cardiovascular diagnosis, prediction. |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-20620</cfResPublId> <cfResPublDate>2012-01-02</cfResPublDate> <cfVol>330</cfVol> <cfIssue>6</cfIssue> <cfStartPage>47</cfStartPage> <cfISSN>1875-0666</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/20620</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Markerii cardiovasculari: valori predictive şi semnificaţii fiziopatologice</cfTitle> <cfKeyw cfLangCode='RO' cfTrans='o'>biomarker; cardiovascular diagnosis; myocardium remodeling; prediction.</cfKeyw> <cfAbstr cfLangCode='EN' cfTrans='o'>The diagnostics arsenal of cardiovascular diseases is updated by the use of specific markers which are approved by European Society of Cardiology, American Heart Association and American College of Cardiology. In this article an actual glance of opportune markers applied in myocardial necrosis, myocardial remodeling and endothelium dysfunction estimation is emphasized. The role of CK-MB, myoglobin and troponins (I and T) is underlined in the necrotic myocardial lesions diagnosis. For myocardium remodeling is basically important estimation of the circulating levels of galectin-3, BNP, connective tissue growth factor and matrix metalloproteinases. Endothelial dysfunction of systemic and coronary arteries is linked to soluble selectines, inflammatory cytokines, lipoprotein-associated phospholipase A2, nitric oxide and asymmetric dimethylarginine assessment.</cfAbstr> <cfAbstr cfLangCode='RU' cfTrans='o'>Диагностический арсенал сердечнососудистых заболеваний усовершенствован при помощи использования специфических маркеров, апробированых Европейской Ассоциацией Кардиологов и Американскими Ассоциациями Кардиологов. В этой статье освещены наиболее Aзначимые маркеры, применяемые в диагностике некроза и ремоделирования миокарда, а также эндотелиальной дисфункции. Показана роль КК- МВ, миоглобина и тропонинов в диагностике некротических повреждений миокарда. Рассмотрено значение галектина-3, натрийуретического пептида В, фактора роста соединительной ткани и матриксных металлопротеиназ в оценке ремоделирования миокарда. Выделена роль селектинов, воспалительных цитокинов, окиси азота, фосфолипазы А2 и ассиметричного диметиларгинина в определении эндотелиальной дисфункции.</cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2012-01-02T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2012-01-02T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-28062</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2012-01-02T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-28062</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-28062-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2012-01-02T24:00:00</cfStartDate> <cfFamilyNames>Ciobanu</cfFamilyNames> <cfFirstNames>Liliana</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>